Elsevier Inc.

SHERPA: Unknown

People

  1. Abu-Rustum
    Abu-Rustum
  2. Chi
    Chi
  3. Lee
    Lee
  4. Giralt
    Giralt
  5. Mulhall
    Mulhall
  6. Perales
    Perales
  7. Sonoda
    Sonoda
  8. Leitao
    Leitao
  9. Wu
    Wu
  10. Wolden
    Wolden

Groups

  1. Department of Medicine (4582)
  2. Surgery (3532)
  3. Survivorship Research (2649)
  4. Solid Tumor Oncology Division (2627)
  5. Radiation Oncology, Department of (2152)
  6. GSK Faculty (1930)
  7. Center for Hematologic Malignancies (1672)
  8. Hematologic Malignancies, Division of (1605)
  9. Gynecology Disease Management Team (1421)
  10. Sloan Kettering Institute Faculty (1413)
Search Within
Formats
  1. Journal Article (7361)
  2. Meeting Abstract (4689)
  3. Review (603)
  4. Book Section (538)
  5. Editorial (247)
  6. Conference Paper (138)
  7. Correspondence (91)
  8. Guidelines (81)
  9. Research Letter (28)
  10. Book Whole (14)
  11. Miscellaneous (14)
Groups
  1. Department of Medicine (4582)
  2. Surgery (3532)
  3. Survivorship Research (2649)
  4. Solid Tumor Oncology Division (2627)
  5. Radiation Oncology, Department of (2152)
  6. GSK Faculty (1930)

More Groups

People
  1. Nadeem Abu-Rustum (461)
  2. Dennis Chi (420)
  3. Nancy Lee (407)
  4. Michael Zelefsky (401)
  5. Sergio Giralt (384)
  6. John Mulhall (376)

More People

Years
  1. 2025 (193)
  2. 2024 (783)
  3. 2023 (759)
  4. 2022 (794)
  5. 2021 (723)
  6. 2020 (714)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2606)
  2. Gynecologic Oncology (1192)
  3. Journal of Thoracic Oncology (966)
  4. Biology of Blood and Marrow Transplantation (815)
  5. European Journal of Cancer (523)
  6. Journal of Sexual Medicine (434)

More Publications

Results (13804)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic Utility of ctDNA Detection in The monarchE Trial of Adjuvant Abemaciclib Plus Endocrine therapy (ET) in HR+, HER2-, Node-positive, High-risk Early Breast Cancer (EBC)
    Meeting Abstract

    Loi, S.; Johnston, S.; Arteaga, C.; Graff, S.; Chandarlapaty, S.; Goetz, M.; Desmedt, C.; Sasano, H.; Liu, D.; Rodrik-Outmezguine, V.; more...
    Breast (2025)

    Fulltext@MSK | Save
  • Survival from ER-positive breast cancer in women who carry a BRCA1 mutation
    Meeting Abstract

    Narod, S.; Lubinski, J.; Wong, S.; Soukupova, J.; Bernstein, R.; Fruscio, R.; Plichta, J.; Lee, M.; Irmejs, A.; Evans, G.; more...
    Breast (2025)

    Fulltext@MSK | Save
  • Genomic And Transcriptomic Profiling of Primary Tumors From Patients with HR+, HER2-, Node-positive, High-risk Early Breast Cancer (EBC) in the monarchE Trial
    Meeting Abstract

    Rubenstein, C. S.; Turner, N.; Reis, J. S.; Goetz, M. P.; Desmedt, C.; Chandarlapaty, S.; Sasano, H.; Arteaga, C. L.; Loi, S.; Graff, S. L.; more...
    Breast (2025)

    Fulltext@MSK | Save
  • Impact of bilateral surgery on time to treatment in patients with breast cancer undergoing mastectomy - a retrospective cohort study
    Meeting Abstract

    Heidinger, M.; Staehelin, S.; Halbeisen, F.; Maggi, N.; Loesch, J. M.; Schwab, F. D.; Kurzeder, C.; Montagna, G.; Weber, W. P.
    Breast (2025)

    Fulltext@MSK | Save
  • Osimertinib (osi) plus datopotamab deruxtecan (Dato-DXd) in patients (pts) with EGFR-mutated (EGFRm) advanced NSCLC (aNSCLC) whose disease progressed on first-line (1L) osi: ORCHARD
    Meeting Abstract

    Le, X.; Hendriks, L.; Morabito, A.; Bonanno, L.; Okamoto, I.; Goldman, J. W.; Yu, H.; Brustugun, O. T.; Halvorsen, T. O.; Kim, Y. J.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Tepotinib in patients ( pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC) from the VISION study: ≥3-year follow-up outcomes
    Meeting Abstract

    Mazieres, J.; Veillon, R.; Cortot, A.; Ferrara, R.; Felip, E.; Garassino, M.; Le, X.; Thomas, M.; Sakai, H.; Smit, E.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • PYNNACLE phase II assessing rezatapopt in patients with advanced solid tumors, including lung cancer, harboring a TP53 Y220C mutation
    Meeting Abstract

    De Miguel, M. J.; Dumbrava, E. E.; Body, A.; Eberst, L.; Frenel, J. S.; Italiano, A.; Johnson, M. L.; Kaczmar, J.; Kummar, S.; Lorusso, P. M.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Integrin-Linked Kinase Drives Drug-Tolerant Persister Cell Survival and EMT in Response to EGFR Inhibition in Lung Adenocarcinoma
    Meeting Abstract

    Shi, R. C. Y.; Farnsworth, D. A.; Febres-Aldana, C. A.; Chow, J. L.; Sheena, R.; Atwal, T.; Marti, J. L. G.; Thomas, K. N.; Lee, C. M.; Awrey, S. J.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Safety and clinical activity of daraxonrasib (RMC-6236) in RAS mutant non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Punekar, S. R.; Hong, D. S.; Luo, J.; Ou, S. H. I.; Johnson, M. L.; Spira, A.; Garrido-Laguna, I.; Goldman, J. W.; Herzberg, B.; Saltos, A.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Dual Targeting of RET and SRC to Treat RET-Positive Non-Small Cell Lung Cancer
    Meeting Abstract

    Son, J.; Rix, L. L. R.; Fang, B.; Welsh, E. A.; Drilon, A.; Koomen, J. M.; Cocco, E.; Rix, U.
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save